Pro-Resolving Mediators

Supports a balanced inflammatory response to maintain homeostasis throughout the body.

Combines pre-resolving mediators with omega-3 fatty acids EPA and DHA to optimize tissue repair and to support brain, nerve, cardiovascular, and immune health.

Ingredient Information

Ingredient Amounts

Serving Size: 1 Gelcaps

Servings Per Container: 60

Pro-Resolving Mediators Details

Pro-Resolving mediators (PRMs) are the end products of the body's metabolism of EPA and DHA. Thorne's Pro-Resolving Mediators supplement includes the precursors the body needs to create pro-resolving mediators - two pre-resolving mediators 17-HDHA and 14-HDHA from DHA and one pre-resolving mediator 18-HEPE from EPA, as well as their parents EPA and DHA, to deliver a one-two punch in support of a balanced inflammatory response. A balanced inflammatory response helps bring the body back into homeostasis after an injury or other insult - essentially helping to ?Ç£resolve?Ç¥ the problem. In fact, groups of PRMs produced in the body are called resolvins and protectins - basically members of the body's ?Ç£cleanup crew.?Ç¥

Benefits of Thorne's Pro-Resolving Mediators formula:

• Provides support for healthy brain structure and cognitive function
• Helps maintain a balanced immune/inflammatory response throughout the body
• Provides relief from the discomfort of a tissue injury
• Promotes clearance of cellular debris - the dead cells and byproducts of the inflammatory process
• Supports exercise recovery

Features

• Includes EPA and DHA in addition to three pre-resolving mediators
• Contains an omega-3 blend with the highest concentration of pre-resolving mediators on the market

Warnings

ALLERGY WARNING

This product is contraindicated in an individual with a history of hypersensitivity to any of its ingredients.

The omega-3 fatty acids in Pro-Resolving Mediators are derived from fish and/or shellfish.

PREGNANCY

If pregnant, consult your health professional before using this product.

INTERACTIONS

There are no known adverse interactions or contraindications at publication date.